From the publishers of The New England Journal of Medicine
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
Some content may require paid access to the site. Subscribe or
purchase a seven-day site pass for the full text of
all our clinical perspectives on medical journal articles, guidelines, and news.
ACOG suggests clinicians should consider transdermal forms of estrogen for their possible thrombosis-sparing effects.
Interventions include providing safety cards as well as contraceptive methods that are less susceptible to partner subversion.
Targeting modifiable factors behind primary cesarean deliveries can reverse the trend.
Notwithstanding this guidance, HT's role in averting osteoporosis should not be overlooked.
Committee states that these highly effective reversible contraceptive methods are ideal for sexually active adolescents.
Once again, the task force recommends against routine screening in asymptomatic women.
Mixed results from trials of extended bisphosphonate treatment leave treatment and monitoring guidelines uncertain.
Data continue to support the benefits of HT for symptom management and fracture risk reduction.
The FDA's approval of over-the-counter access to emergency contraception without age restrictions was recently blocked at the federal level.
Lowering the U.S. cesarean delivery rate requires a multifaceted approach.